- Advancing Systemic Therapy in Gastric Cancer: Key Updates From the Korean Practice Guidelines for Gastric Cancer 2024
-
Ryu MH, Ryu KW
- KMID: 2564652
- J Gastric Cancer.
- 2025 Jan;25(1):1-4.
- doi: 10.5230/jgc.2025.25.e6
-
- CITED
-
- Close
- SHARE
-
- Close
- Updated Review of Proximal Gastrectomy for Gastric Cancer or Cancer of the Gastroesophageal Junction
-
Irino T, Ohashi M, Hayami M, Makuuchi R, Ri M, Sano T, Yamaguchi T, Nunobe S
- KMID: 2564660
- J Gastric Cancer.
- 2025 Jan;25(1):228-246.
- doi: 10.5230/jgc.2025.25.e12
Proximal gastrectomy (PG) has reemerged as a viable surgical option for managing proximal gastric cancer and gastroesophageal junction cancer, particularly for early-stage tumors, offering potential advantages over total gastrectomy (TG).... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Gastric Cancer AssociationLed Nationwide Survey on Surgically Treated Gastric Cancers in 2023
-
Kim DJ, Song JH, Park JH, Kim S, Park SH, Shin CM, Kwak Y, Bang K, Gong Cs, Oh SE, Kim YM, Park YS, Kim J, Jung JE, Jung MR, Eom BW, Park KB, Chung JH, Lee SI, Son YG, Kim DH, Seo SH, Lee S, Seo WJ, Park DJ, Kim Y, Kim JJ, Park KB, Cho I, Ahn HS, Oh SJ, Lee JH, Lee H, Gong SC, Choi C, Park JH, Kim EY, Lee CM, Yun JH, Oh SJ, Lee E, Jeong SA, Bae JM, Min JS, Chae Hd, Kim SG, Park D, Kang DB, Kim H, Lee SS, Choi SI, Hwang SH, Kim SM, Lee MS, Kim SH, Jeong SH, Yang Y, Baik Y, Eom SS, Jeong I, Jung YJ, Park JM, Lee JW, Park J, Kim KH, Lee KG, Lee J, Oh S, Park JH, Kim JW, TICotKGCA
- KMID: 2564654
- J Gastric Cancer.
- 2025 Jan;25(1):115-132.
- doi: 10.5230/jgc.2025.25.e8
Purpose: Since 1995, the Korean Gastric Cancer Association (KGCA) has been periodically conducting nationwide surveys on patients with surgically treated gastric cancer. This study details the results of the survey... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)
-
Kim IH, Kang SJ, Choi W, Seo AN, Eom BW, Kang B, Kim BJ, Min BH, Tae CH, Choi CI, Lee Ck, An HJ, Byun HK, Im HS, Kim HD, Cho JH, Pak K, Kim JJ, Bae JS, Yu JI, Lee JW, Choi J, Kim JH, Choi M, Jung MR, Seo N, Eom SS, Ahn S, Kim SJ, Lee SH, Lim SH, Kim TH, Han HS, oboTDWGftKPGfGC2
- KMID: 2564653
- J Gastric Cancer.
- 2025 Jan;25(1):5-114.
- doi: 10.5230/jgc.2025.25.e11
Gastric cancer is one of the most common cancers in both Korea and worldwide. Since 2004, the Korean Practice Guidelines for Gastric Cancer have been regularly updated, with the 4th... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines: 2024 Update
-
Eom SS, Ryu KW, Han HS, Kong SH
- KMID: 2564656
- J Gastric Cancer.
- 2025 Jan;25(1):153-176.
- doi: 10.5230/jgc.2025.25.e10
Differences in demographics, medical expertise, and patient healthcare resources across countries have led to significant variations in guidelines. In light of these differences, in this review, we aimed to explore... -
- CITED
-
- Close
- SHARE
-
- Close
- Function Preserving Gastrectomy and Quality of Life
-
Kim J, Lee HJ
- KMID: 2564661
- J Gastric Cancer.
- 2025 Jan;25(1):247-260.
- doi: 10.5230/jgc.2025.25.e7
Advances in gastric cancer screening have enabled earlier detection, shifting the focus of treatment toward preserving patients’ quality of life (QoL). Function-preserving gastrectomy (FPG), including pylorus-preserving gastrectomy, proximal gastrectomy, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Management Strategy of Non-curative ESD in Gastric Cancer: Curative Criteria, and the Critical Building Block for Determining Beyond It
-
Lee H
- KMID: 2564659
- J Gastric Cancer.
- 2025 Jan;25(1):210-227.
- doi: 10.5230/jgc.2025.25.e5
Endoscopic submucosal dissection is performed in cases of early gastric cancer, where the risk of lymph node metastasis (LNM) is expected to be negligible, and 12%–21% of these patients are... -
- CITED
-
- Close
- SHARE
-
- Close
- Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024
-
Kim TH, Uyama I, Rha SY, Bencivenga M, An J, Wyrwicz L, Koo DH, Hillegersberg Rv, Lee KW, Li G, Yoshikawa T, Badgwell B, Lorenzen S, Kim IH, Lee IS, Han HS, Hoon H
- KMID: 2564655
- J Gastric Cancer.
- 2025 Jan;25(1):133-152.
- doi: 10.5230/jgc.2025.25.e9
Conversion therapy is a treatment strategy that shifts from palliative systemic therapy to curative surgical treatment for primary and/or metastatic stage IV gastric cancer (GC). To address its clinical statements, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Spatial and Temporal Tumor Heterogeneity in Gastric Cancer: Discordance of Predictive Biomarkers
-
Lee HS
- KMID: 2564658
- J Gastric Cancer.
- 2025 Jan;25(1):192-209.
- doi: 10.5230/jgc.2025.25.e3
Gastric cancer (GC) is a highly heterogeneous disease that varies in both histological presentation and genetic characteristics. Recent advances in the treatment of metastatic and unresectable GC have made several... -
- CITED
-
- Close
- SHARE
-
- Close
- PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
-
Cho Y, Ahn S, Kim KM
- KMID: 2564657
- J Gastric Cancer.
- 2025 Jan;25(1):177-191.
- doi: 10.5230/jgc.2025.25.e4
Combining chemotherapy with immune checkpoint inhibitors (ICIs) that target the programmed death-1 (PD-1) protein has been shown to be a clinically effective first-line treatment for human epidermal growth factor receptor... -
- CITED
-
- Close
- SHARE
-
- Close
